M-CSF induces vascular endothelial growth factor production and angiogenic activity from human monocytes

Journal of Immunology

Volumn 171, Issue 5, 2003, Pages 2637-2643

  Eubank, Tim D ^a   Galloway, Michelle ^a   Montague, Christine M ^a   Waldman, W James ^a   Marsh, Clay B ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b Pulmonary and Critical Care Division   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; COLONY STIMULATING FACTOR 1; GROWTH FACTOR; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL CULTURE; CELL FREE SYSTEM; CELL LYSATE; CELL SURVIVAL; CELL TRANSFORMATION; CONTROLLED STUDY; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; MACROPHAGE; METASTASIS; MONOCYTE;

EID: 0041929158     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.5.2637     Document Type: Article

References (39)

1. Dvorak, H. F., T. M. Sioussat, L. F. Brown, B. Berse, J. A. Nagy, A. Sotrel, E. J. Manseau, W. L. Van De, and D. R. Senger. 1991. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. J. Exp. Med. 174:1275.
2. Dvorak, H. F. 2000. VPF/VEGF and the angiogenic response. Semin. Perinatol. 24:75.
3. Hamada, K., Y. Oike, N. Takakura, Y. Ito, L. Jussila, D. J. Dumont, K. Alitalo, and T. Suda. 2000. VEGF-C signaling pathways through VEGFR-2 and VEGFR-3 in vasculoangiogenesis and hematopoiesis. Blood 96:3793.
4. Romano, D. P., A. Mangoni, G. Zambruno, G. Spinetti, G. Melillo, M. Napolitano, and M. C. Capogrossi. 2002. Adenovirus-mediated VEGF(165) gene transfer enhances wound healing by promoting angiogenesis in CD1 diabetic mice. Gene Ther. 9:1271.
5. Senger, D. R., W. L. Van De, L. F. Brown, J. A. Nagy, K. T. Yeo, T. K. Yeo, B. Berse, R. W. Jackman, A. M. Dvorak, and H. F. Dvorak. 1993. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev. 12:303.
6. Gerber, H. P., A. K. Malik, G. P. Solar, D. Sherman, X. H. Liang, G. Meng, K. Hong, J. C. Marsters, and N. Ferrara. 2002. VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature 417:954.
7. O'Reilly, M. S., T. Boehm, Y. Shing, N. Fukai, G. Vasios, W. S. Lane, E. Flynn, J. R. Birkhead, B. R. Olsen, and J. Folkman. 1997. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88:277.
8. O'Reilly, M. S., L. Holmgren, Y. Shing, C. Chen, R. A. Rosenthal, M. Moses, W. S. Lane, Y. Cao, E. H. Sage, and J. Folkman. 1994. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79:315.
9. Perletti, G., P. Concari, R. Giardini, E. Marras, F. Piccinini, J. Folkman, and L. Chen. 2000. Antitumor activity of endostatin against carcinogen-induced rat primary mammary tumors. Cancer Res. 60:1793.
10. Cao, Y., M. S. O'Reilly, B. Marshall, E. Flynn, R. W. Ji, and J. Folkman. 1998. Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases. J. Clin. Invest. 101:1055.
11. Lin, E. Y., A. V. Nguyen, R. G. Russell, and J. W. Pollard. 2001. Colony-stimulating factor I promotes progression of mammary tumors to malignancy. J. Exp. Med. 193:727.
12. Aharinejad, S., D. Abraham, P. Paulus, H. Abri, M. Hofmann, K. Grossschmidt, R. Schafer, E. R. Stanley, and R. Hofbauer. 2002. Colony-stimulating factor-I antisense treatment suppresses growth of human tumor xenografts in mice. Cancer Res. 62:5317.
13. Achen, M. G., and S. A. Stacker. 1998. The vascular endothelial growth factor family; proteins which guide the development of the vasculature. Int. J. Exp. Pathol. 79:255.
14. Hawighorst, T., P. Velasco, M. Streit, Y. K. Hong, T. R. Kyriakides, L. F. Brown, P. Bornstein, and M. Detmar. 2001. Thrombospondin-2 plays a protective role in multistep carcinogenesis: a novel host anti-tumor defense mechanism. EMBO J. 20:2631.
15. Hiraoka, N., E. Allen, I. J. Apel, M. R. Gyetko, and S. J. Weiss. 1998. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell 95:365.
16. Matsumoto, T., and L. Claesson-Welsh. 2001. VEGF receptor signal transduction. Sci. STKE. 2001:RE21.
17. Hudlicka, O., M. Milkiewicz, M. A. Cotter, and M. D. Brown. 2002. Hypoxia and expression of VEGF-A protein in relation to capillary growth in electrically stimulated rat and rabbit skeletal muscles. Exp. Physiol. 87:373.
18. Ferrara, N. 1999. Vascular endothelial growth factor: molecular and biological aspects. Curr. Top. Microbiol. Immunol. 237:1.
19. Jakeman, L. B., J. Winer, G. L. Bennett, C. A. Altar, and N. Ferrara. 1992. Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues. J. Clin. Invest. 89:244.
20. Jakeman, L. B., M. Armanini, H. S. Phillips, and N. Ferrara. 1993. Developmental expression of binding sites and messenger ribonucleic acid for vascular endothelial growth factor suggests a role for this protein in vasculogenesis and angiogenesis. Endocrinology 133:848.
21. Kliche, S., and J. Waltenberger. 2001. VEGF receptor signaling and endothelial function. IUBMB Life 52:61.
22. Shibuya, M. 2001. Structure and function of VEGF/VEGF-receptor system involved in angiogenesis. Cell Struct. Funct. 26:25.
23. Sato, Y., S. Kanno, N. Oda, M. Abe, M. Ito, K. Shitara, and M. Shibuya. 2000. Properties of two VEGF receptors, Flt-1 and KDR, in signal transduction. Ann. NY Acad. Sci. 902:201.
24. Ortega, N., H. Hutchings, and J. Plouet. 1999. Signal relays in the VEGF system. Front. Biosci. 4:D141.
25. Marsh, C. B., R. J. Pomerantz, J. M. Parker, A. V. Winnard, E. L. J. Mazzaferri, N. Moldovan, T. W. Kelley, Beck, E. and M. D. Wewers. 1999. Regulation of monocyte survival in vitro by deposited IgG: role of MCSF. J. Immunol. 162:6217.
26. Feldman, A. L., H. R. Alexander, Jr., J. C. Yang, W. M. Linehan, R. A. Eyler, M. S. Miller, S. M. Steinberg, and S. K. Libutti. 2002. Prospective analysis of circulating endostatin levels in patients with renal cell carcinoma. Cancer 95:1637.
27. Salcedo, R., J. H. Resau, D. Halverson, E. A. Hudson, M. Dambach, D. Powell, K. Wasserman, and J. J. Oppenheim. 2000. Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells. FASEB J. 14:2055.
28. Zelzer, E., D. J. Glotzer, C. Hartmann, D. Thomas, N. Fukai, S. Soker, and B. R. Olsen. 2001. Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2. Mech. Dev. 106:97.
29. Clauss, M. 2000. Molecular biology of the VEGF and the VEGF receptor family. Semin. Thromb. Hemost. 26:561.
30. Ferrara, N., and B. Keyt. 1997. Vascular endothelial growth factor: basic biology and clinical implications. EXS 79:209.
31. Ferrara, N., and T. Davis-Smyth. 1997. The biology of vascular endothelial growth factor. Endocr. Rev. 18:4.
32. Martiny-Baron, G., and D. Marme. 1995. VEGF-mediated tumour angiogenesis: a new target for cancer therapy. Curr. Opin. Biotechnol. 6:675.
33. Ferrara, N. 2002. Timeline: VEGF and the quest for tumour angiogenesis factors. Nat. Rev. Cancer. 2:795.
34. Verheul, H. M., and H. M. Pinedo. 2000. The role of vascular endothelial growth factor (VEGF) in tumor angiogenesis and early clinical development of VEGF-receptor kinase inhibitors. Clin. Breast Cancer 1(Suppl. 1):S80.
35. Im, S. A., J. S. Kim, C. Gomez-Manzano, J. Fueyo, T. J. Liu, M. S. Cho, C. M. Seong, S. N. Lee, Y. K. Hong, and W. K. Yung. 2001. Inhibition of breast cancer growth in vivo by antiangiogenesis gene therapy with adenovirus-mediated antisense-VEGF. Br. J. Cancer. 84:1252.
36. Smith, J. D., E. Trogan, M. Ginsberg, C. Grigaux, J. Tian, and M. Miyata. 1995. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc. Natl. Acad. Sci. USA 92:8264.
37. Shi, C. W., W. S. Lee, Q. He, D. Zhang, D. L. Fletcher, Jr., J. B. Newell, and E. Haber. 1996. Immunologic basis of transplant-associated arteriosclerosis. Proc. Natl. Acad. Sci. USA 93:4051.
38. Yang, Y. H., and J. A. Hamilton. 2001. Dependence of interleukin-1-induced arthritis on granulocyte-macrophage colony-stimulating factor. Arthritis Rheum. 44:111.
39. Sapi, E., and B. M. Kacinski. 1999. The role of CSF-1 in normal and neoplastic breast physiology. Proc. Soc. Exp. Biol. Med. 220:1.